| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |